Evidence map›Paper›PMID 40379611›Full record

ArticleCell death & disease2025

ZSCAN21 mediates the pathogenic transcriptional induction of α-synuclein in cellular and animal models of Parkinson's disease.

Alina Kozoriz, Stéphan Mora, Maria-Alessandra Damiano, Iria Carballo-Carbajal, Annabelle Parent, Lorena Kumarasinghe, Miquel Vila, Iréna Lassot, Solange Desagher

Abstract read
In one paragraph

Article in Cell death & disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alina KozorizIGMM, University of Montpellier, CNRS, Montpellier, France.ORCID http://orcid.org/0000-0002-7937-3701
Stéphan MoraIGMM, University of Montpellier, CNRS, Montpellier, France.ORCID http://orcid.org/0000-0001-9818-1695
Maria-Alessandra DamianoIGMM, University of Montpellier, CNRS, Montpellier, France.
Iria Carballo-CarbajalNeurodegenerative Diseases Research Group, Vall d'Hebron Research Institute (VHIR)-Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Barcelona, Spain.
Annabelle ParentNeurodegenerative Diseases Research Group, Vall d'Hebron Research Institute (VHIR)-Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Barcelona, Spain.ORCID http://orcid.org/0000-0002-6195-812X
Lorena KumarasingheIRIM, University of Montpellier, CNRS, Montpellier, France.ORCID http://orcid.org/0000-0002-8993-3565
Miquel VilaNeurodegenerative Diseases Research Group, Vall d'Hebron Research Institute (VHIR)-Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Barcelona, Spain.ORCID http://orcid.org/0000-0002-1352-989X
Iréna Lassot *IGMM, University of Montpellier, CNRS, Montpellier, France.ORCID http://orcid.org/0000-0001-7059-7963
Solange Desagher *IGMM, University of Montpellier, CNRS, Montpellier, France. solange.desagher@irim.cnrs.fr.ORCID http://orcid.org/0000-0002-3735-7527

Funding

EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 Marie Skłodowska-Curie Actions (H2020 Excellent Science - Marie Skłodowska-Curie Actions) 813599Fondation pour la Recherche Médicale (Foundation for Medical Research in France) MND202310017917Michael J. Fox Foundation for Parkinson's Research (Michael J. Fox Foundation) 12372
6 · The paper itself

Abstract

The expression level of α-synuclein is thought to play a crucial role in the pathogenesis of Parkinson's disease. However, little is known about the molecular mechanisms regulating the transcription of its gene, SNCA, particularly in the context of the disease. The transcription factor ZSCAN21 has been shown to act on SNCA, but whether ZSCAN21 is actually involved in the induction of SNCA transcription in Parkinson's disease is unknown. To address this question, we used the MPTP mouse model and LUHMES-derived dopaminergic neuronal spheroids, subjected to Parkinson's disease-related neurotoxins and mutations. We show that MPP

Indexed as

alpha-SynucleinParkinson DiseaseTranscription FactorsAnimalsDisease Models, AnimalDopaminergic NeuronsHumansMaleMiceMice, Inbred C57BLSpheroids, CellularSubstantia NigraTranscription, GeneticTripartite Motif ProteinsUbiquitin-Protein Ligasesalpha-SynucleinTranscription FactorsTripartite Motif ProteinsUbiquitin-Protein Ligases

Identifiers

PMID40379611
PMCPMC12084422

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.